- Home
- OBT vs ABEO Comparison
OBT vs ABEO Comparison
Compare OBT & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBT
- ABEO
- Stock Information
- Founded
- OBT 1892
- ABEO 1974
- Country
- OBT United States
- ABEO United States
- Employees
- OBT N/A
- ABEO N/A
- Industry
- OBT Major Banks
- ABEO Biotechnology: Pharmaceutical Preparations
- Sector
- OBT Finance
- ABEO Health Care
- Exchange
- OBT Nasdaq
- ABEO Nasdaq
- Market Cap
- OBT 267.9M
- ABEO 260.1M
- IPO Year
- OBT N/A
- ABEO 1980
- Fundamental
- Price
- OBT $25.80
- ABEO $5.27
- Analyst Decision
- OBT Buy
- ABEO Strong Buy
- Analyst Count
- OBT 1
- ABEO 5
- Target Price
- OBT $35.50
- ABEO $18.00
- AVG Volume (30 Days)
- OBT 22.7K
- ABEO 3.0M
- Earning Date
- OBT 04-30-2025
- ABEO 05-19-2025
- Dividend Yield
- OBT 1.91%
- ABEO N/A
- EPS Growth
- OBT N/A
- ABEO N/A
- EPS
- OBT 2.41
- ABEO N/A
- Revenue
- OBT $100,883,000.00
- ABEO N/A
- Revenue This Year
- OBT $12.69
- ABEO N/A
- Revenue Next Year
- OBT $6.00
- ABEO $539.93
- P/E Ratio
- OBT $10.54
- ABEO N/A
- Revenue Growth
- OBT N/A
- ABEO N/A
- 52 Week Low
- OBT $20.97
- ABEO $3.93
- 52 Week High
- OBT $33.06
- ABEO $7.32
- Technical
- Relative Strength Index (RSI)
- OBT 60.03
- ABEO 47.62
- Support Level
- OBT $24.18
- ABEO $5.12
- Resistance Level
- OBT $26.67
- ABEO $7.08
- Average True Range (ATR)
- OBT 1.26
- ABEO 0.58
- MACD
- OBT 0.33
- ABEO -0.04
- Stochastic Oscillator
- OBT 76.01
- ABEO 16.33
About OBT Orange County Bancorp Inc.
Orange County Bancorp Inc provides banking services. Its services include personal banking services such as personal loans, personal savings, business loans, business savings, and Internet banking among others. The company provides commercial and consumer banking services to individuals, small businesses, and local municipal governments as well as trust and investment services through the Bank and HVIA. Its segment includes banking and wealth management. The company generates maximum revenue from the banking segment.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.